Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
Psyched：暗示性與迷幻藥的影響、歐盟的700萬美元研究基金、澳大利亞的治療方案、BZ播客等
New Study Reveals Suggestibility's Role In Antidepressant Effects Of Psilocybin Therapy
新研究揭示了暗示性在迷幻藥療法的抗抑鬱作用中的作用
A new study led by Balázs Szigeti and with involvement of researchers Brandon Weiss, Fernando E Rosas, David Erritzoe, David Nutt and Robin Carhart-Harris found evidence of suggestibility predicting an antidepressant response for patients receiving psilocybin therapy.
由巴拉茲·西蓋蒂領導的一項新研究，研究人員布蘭登·韋斯、費爾南多·羅薩斯、大衛·埃裏佐、大衛·納特和羅賓·卡哈特-哈里斯參與了這項新研究，發現了可以預測接受迷幻藥治療的患者會出現抗抑鬱藥反應的證據。
The study aimed to understand the link between pre-trial expectancy, suggestibility and response to treatment in a previously conducted clinical trial comparing escitalopram and COMPASS Pathways' (NASDAQ:CMPS) synthetic psilocybin, COMP360, in the treatment of 55 patients with Major Depressive Disorder (MDD.) Read more HERE.
該研究旨在了解先前進行的一項臨床試驗，比較了依他普侖和COMPASS Pathways（納斯達克股票代碼：CMPS）合成迷幻藥（COMP360）治療55名重度抑鬱症（MDD）患者的臨床試驗中的試驗前預期、建議性和治療反應之間的聯繫。在這裏閱讀更多。
EU Allocates Funds To Study...
歐盟撥出資...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。